Valuation: BrainsWay Ltd.

Market Cap 600M 0 525M 484M 448M 850M 57.27B 864M 5.8B 2.27B 28.12B 2.25B 2.2B 97.41B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 600M 0 525M 484M 448M 850M 57.27B 864M 5.8B 2.27B 28.12B 2.25B 2.2B 97.41B EV / Sales 2026 *
8.8x
EV / Sales 2027 * 7.06x
Free-Float
90.48%
Yield 2026 *
-
Yield 2027 * -
1 day-0.72%
1 week-2.52%
Current month-0.87%
1 month+6.24%
3 months+7.60%
6 months+22.65%
Current year+45.92%
1 week 4,434
Extreme 4434
4,930
1 month 4,000
Extreme 4000
4,930
Current year 3,080
Extreme 3080
5,123
1 year 1,962
Extreme 1962
5,123
3 years 400
Extreme 400
5,123
5 years 272
Extreme 272
5,123
10 years 272
Extreme 272
5,123
Manager TitleAgeSince
Chief Executive Officer 54 2023-02-12
Chief Tech/Sci/R&D Officer 56 2006-04-30
Director of Finance/CFO 50 2023-05-22
Director TitleAgeSince
Chairman 74 2002-12-31
Director/Board Member 70 2006-10-31
Director/Board Member 56 2019-06-16
Date Insider Type Main position Quantity % Market Cap.
06-14Sell

Chief Technology Officer

-5,000 0.0125%
06-01Sell

Founder

-3,000 0.0075%
05-25Sell

Director

-7,980 0.0399%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%-2.52%+107.74%+1,026.48% 604M
+2.33%-0.46%+24.09%+0.81% 190B
-0.83%-3.11%-21.85%+21.30% 147B
+2.38%-1.53%-3.02%-16.88% 135B
+0.12%-0.89%-56.55%-15.10% 66.6B
-2.51%-3.11%+18.45%-0.22% 53.92B
+0.38%-1.66%-27.47%-30.84% 43.57B
+2.79%+1.32%+9.16%+11.87% 36.45B
+2.14%-0.91%+7.62%+42.00% 36.15B
+1.15%-0.82%-18.78%-4.02% 29.69B
Average +0.78%+1.08%+3.94%+103.54% 73.86B
Weighted average by Cap. +1.04%+1.62%-3.93%+1.48%

Financials

2026 *2027 *
Net sales 68.15M 0 59.62M 54.98M 50.87M 96.55M 6.5B 98.16M 658M 258M 3.19B 256M 250M 11.06B 84.98M 0 74.34M 68.56M 63.43M 120M 8.11B 122M 821M 322M 3.98B 319M 312M 13.8B
Net income 13.23M 0 11.57M 10.67M 9.88M 18.75M 1.26B 19.06M 128M 50.11M 620M 49.67M 48.6M 2.15B 22.2M 0 19.42M 17.91M 16.57M 31.46M 2.12B 31.98M 215M 84.09M 1.04B 83.35M 81.55M 3.61B
Net Debt - -
Logo BrainsWay Ltd.
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Employees
129
Date Price Change Volume
26-07-09 ILA 4,560.00 -0.72% 33,069
26-07-08 ILA 4,593.00 -2.46% 55,415
26-07-07 ILA 4,709.00 -1.07% 44,095
26-07-06 ILA 4,760.00 +0.21% 64,174
26-07-03 ILA 4,750.00 +1.54% 45,975

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BWAY Stock